Introducing Gavi’s new Interim CEO

David Marlow joined Gavi as Chief Operating Officer in July 2022. His primary focus was to enhance Gavi’s operational excellence, drive innovation and evolve Gavi`s culture within the organisation and across the Vaccine Alliance.

26 June 2023
2 min read
by Olly Cann
Republish this article

Disclaimer

If you would like to republish this article, please follow these steps: use the HTML below; do not edit the text; include the author’s byline; credit VaccinesWork as the original source; and include the page view counter script.
<article> <h1> <span>Introducing Gavi’s new Interim CEO</span> </h1> <div><p>David Marlow joined Gavi as Chief Operating Officer in July 2022. His primary focus was to enhance Gavi’s operational excellence, drive innovation and evolve Gavi`s culture within the organisation and across the Vaccine Alliance.</p> </div> <ul> <li> <b>26 June 2023</b> </li> <li> <b class="me-2">by</b> <span> <a href="https://www.gavi.org/vaccineswork/authors/olly-cann" hreflang="en">Olly Cann</a> </span> </li> </ul> <div> <div> <div> <div> <div> <p> </p> <p>During his 30-year career, David has earned a reputation as a transformational global life sciences and social responsibility executive who has driven significant impact across multiple organisations.</p> <blockquote> <h2>A financial expert and chartered accountant who began his career in audit, David has a passion for people and cultures and has delivered significant business value through diversity and inclusion excellence and talent development.</h2> </blockquote> <p>Prior to joining Gavi, he served as Chief Operations Officer of the Mastercard Foundation, one of the largest private foundations in the world. This role provided him with the opportunity to leverage his extensive private sector experience with his personal ambition to give back to society. Among his accomplishments there, David led the redesign and implementation of a new operating model and played a key role in designing and implementing a US$ 1.5 billion, two-year "saving lives and livelihoods" programme to secure COVID-19 vaccines for the African continent.</p> <div> <h4>Have you read?</h4> <ul> <li><a href="https://www.gavi.org/vaccineswork/alliance-never-rests-preview-whats-coming-next-weeks-gavi-board-meeting" title="“The Alliance never rests”: A preview of what’s coming at next week’s Gavi Board meeting">“The Alliance never rests”: A preview of what’s coming at next week’s Gavi Board meeting</a></li> <li><a href="https://www.gavi.org/vaccineswork/poetry-prevention" title="The poetry of prevention">The poetry of prevention</a></li> <li><a href="https://www.gavi.org/vaccineswork/picturing-power-vaccines" title="Picturing the Power of Vaccines">Picturing the Power of Vaccines</a></li> </ul> </div> <p>Before joining Mastercard Foundation, David was a senior executive at the pharmaceutical company, Bristol Myers Squibb (BMS). In his last role there, as Senior Vice President and Company Transformation Lead, David led the design and implementation of a multiyear transformation programme and a new organisation-wide operating model. Prior executive roles include Senior Vice President, Finance Operations at BMS; Vice President, Finance at Mead Johnson Nutrition; and Global Divisional Controller at Philips Medical Systems.</p> <p>A financial expert and chartered accountant who began his career in audit, David has a passion for people and cultures and has delivered significant business value through diversity and inclusion excellence and talent development. He has strengthened operations and finance pipelines of talent, capabilities and culture by pioneering the design and implementation of people development and mentorship frameworks, diversity and inclusion, and culture programmes.</p> </div> </div> </div> </div> </div> <p> <a target="_blank" rel="noopener noreferrer" href="https://www.gavi.org/vaccineswork/introducing-gavis-new-interim-ceo">Original article</a> </p><p>This article was originally published on <a target="_blank" rel="noopener noreferrer" href="https://www.gavi.org/vaccineswork">VaccinesWork</a> </p><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-M7H54VD');</script><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-M7H54VD" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript></article>

David Marlow speaking during the Global Vaccine Impact Conference, Madrid, Spain. 14 June 2023. Credit: Benedikt V. Loebell

During his 30-year career, David has earned a reputation as a transformational global life sciences and social responsibility executive who has driven significant impact across multiple organisations.

A financial expert and chartered accountant who began his career in audit, David has a passion for people and cultures and has delivered significant business value through diversity and inclusion excellence and talent development.

Prior to joining Gavi, he served as Chief Operations Officer of the Mastercard Foundation, one of the largest private foundations in the world. This role provided him with the opportunity to leverage his extensive private sector experience with his personal ambition to give back to society. Among his accomplishments there, David led the redesign and implementation of a new operating model and played a key role in designing and implementing a US$ 1.5 billion, two-year "saving lives and livelihoods" programme to secure COVID-19 vaccines for the African continent.

Have you read?

Before joining Mastercard Foundation, David was a senior executive at the pharmaceutical company, Bristol Myers Squibb (BMS). In his last role there, as Senior Vice President and Company Transformation Lead, David led the design and implementation of a multiyear transformation programme and a new organisation-wide operating model. Prior executive roles include Senior Vice President, Finance Operations at BMS; Vice President, Finance at Mead Johnson Nutrition; and Global Divisional Controller at Philips Medical Systems.

A financial expert and chartered accountant who began his career in audit, David has a passion for people and cultures and has delivered significant business value through diversity and inclusion excellence and talent development. He has strengthened operations and finance pipelines of talent, capabilities and culture by pioneering the design and implementation of people development and mentorship frameworks, diversity and inclusion, and culture programmes.